Tuesday, 5 November 2019

Questions (443)

Alan Kelly

Question:

443. Deputy Alan Kelly asked the Minister for Health if the HSE has under the best value biologic process set targets for biosimilar uptake across the designated treatment areas; if so, the targets for 2019 and 2020 in terms of both volume of prescriptions and the share of biosimilar prescriptions versus originator subscriptions for the designated treatment areas; and if he will make a statement on the matter. [44253/19]

View answer

Written answers (Question to Health)

As this is an operational matter it has been referred to the Health Service Executive for direct reply to the Deputy.